State-of-the-art magnetic resonance imaging of pancreatic cancer

Topics in Magnetic Resonance Imaging

Volumn 18, Issue 6, 2007, Pages 421-429

  Schima, Wolfgang ^a   Ba Ssalamah, Ahmed ^a   Goetzinger, Peter ^a   Scharitzer, Martina ^a   Koelblinger, Claus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

3.0 T; Adenocarcinoma; Cancer; Computed tomography; Magnetic resonance imaging; Neuroendocrine cancer; Pancreas

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM; MANGAFODIPIR;

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERINSULINEMIA; IMAGE ANALYSIS; INCIDENCE; LIVER METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYMPTOM; TREATMENT CONTRAINDICATION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; CARCINOMA, NEUROENDOCRINE; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM METASTASIS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39849096927     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/rmr.0b013e31816459e0     Document Type: Review

References (43)

1. Group USCSW. United States Cancer Statistics: 2002 Incidence and Mortality. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005.
2. Wood HE, Gupta S, Kang JY, et al. Pancreatic cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther. 2006;23:1205-1214.
3. Levi F, Lucchini F, Negri E, et al. Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas. 2003;27:139-142.
4. Lowenfels AB, Maisonneuve PM, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993;328:1435-1437.
5. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst. 1997;89:442-446.
6. Warshaw AL, Gu Z, Wittenberg J, et al. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg. 1990;125:230-233.
7. Tsiotos GG, Farnell MB, Sarr MG. Are the results of pancreatectomy for pancreatic cancer improving? World J Surg. 1999;23:913-919.
8. Trede M, Schwall G, Saeger H-D. Survival after pancreatoduodenectomy. 118 Consecutive resections without an operative mortality. Ann Surg. 1990;211:447-458.
9. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002:157-164.
10. Hussain SM, Wielopolski PA, Martin DR. Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future? Top Magn Reson Imaging. 2005;16:325-335.
11. Keppke AL, Miller FH. Magnetic resonance imaging of the pancreas: the future is now. Semin Ultrasound CT MR. 2005;26:132-152.
12. Schima W, Ba-Ssalamah A, Kolblinger C, et al. Pancreatic adenocarcinoma. Eur Radiol. 2007;17:638-649.
13. Outwater EK, Mitchell DG. MR imaging techniques for evaluation of the pancreas. Top Magn Reson Imaging. 1996;8:248-264.
14. Outwater EK, Siegelman ES. MR imaging of pancreatic disorders. Top Magn Reson Imaging. 1996;8:265-289.
15. Gehl H-B, Vorwerk D, Klose K-C, et al. Pancreatic enhancement after low-dose infusion of Mn-DPDP. Radiology. 1991;180:337-339.
16. Gehl H-B, Urhahn R, Bohndorf K, et al. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. Radiology. 1993;186:795-798.
17. Kettritz U, Warshauer DM, Brown ED, et al. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Eur Radiol. 1996;6:14-18.
18. Schima W, Függer R, Schober E, et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir-enhanced MRI and contrast-enhanced helical hydro-CT. AJR. 2002;179:717-724.
19. Schima W, Függer R. Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT. Eur Radiol. 2002;12:2998-3008.
20. Spencer JA, Ward J, Guthrie JA, et al. Assessment of resectability of pancreatic cancer with dynamic contrast-enhanced MR imaging: technique, surgical correlation and patient outcome. Eur Radiol. 1998;8:23-29.
21. Semelka RC, Kelekis NL, John G, et al. Ampullary carcinoma: demonstration by current MR techniques. J Magn Reson Imaging. 1997;7:153-156.
22. Irie H, Honda H, Shinozaki K, et al. MR imaging of ampullary carcinomas. J Comput Assist Tomogr. 2002;26:711-717.
23. Ichikawa T, Haradome H, Hachiya J, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology. 1997;202:655-662.
24. Irie H, Honda H, Kaneko K, et al. Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging. 1997;22:429-433.
25. Romijn MG, Stoker J, van Eijck CHJ, et al. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer. J Magn Reson Imaging. 2000;12:261-268.
26. Grenacher L, Klauss M, Dukic L, et al. Hochauflösende Bildgebung beim Pankreaskarzinom: prospektiver Vergleich von MRT und 4-Zeilen-Spiral-CT. Fortschr Röntgenstr. 2004;176:1624-1633.
27. Bipat S, Phoa SSKS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic carcinoma. J Comput Assist Tomogr. 2005;29:438-445.
28. Lu DSK, Reber HA, Krasny RM, et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase thin section helical CT. AJR. 1997;168:1439-1443.
29. O'Malley ME, Boland GWL, Wood BJ, et al. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR. 1999;173:1513-1518.
30. Yamada Y, Mori H, Kiyosue H, et al. CT assessment of the inferior peripancreatic veins: clinical significance. AJR. 2000;174:677-684.
31. Obuz F, Dicle O, Coker A, et al. Pancreatic adenocarcinoma: detection and staging with dynamic MR imaging. Eur J Radiol. 2001;38:146-150.
32. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability - report of the Radiology Diagnostic Oncology Study Group. Radiology. 1995; 195:327-332.
33. Trede M, Rumstadt B, Wendl K, et al. Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors. Ann Surg. 1997;226:393-407.
34. Miller FH, Rini NJ, Keppke AL. MRI of adenocarcinoma of the pancreas. AJR. 2006;187:W365-W374.
35. Ichikawa T, Sou H, Araki T, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107-116.
36. Shudo R, Yazaki Y, Sakurai S, et al. Groove pancreatitis: report of a case and review of the clinical and radiologic features of groove pancreatitis reported in Japan. Intern Med. 2002;41:537-542.
37. Irie H, Honda H, Kuroiwa T, et al. MRI of groove pancreatitis. J Comput Assist Tomogr. 1998;22:651-655.
38. Rha SE, Jung SE, Lee KL, et al. CT and MR imaging findings of endocrine tumor according to WHO classification. Eur J Radiol. 2007;62:371-377.
39. Noone TC, Hosey J, Firat Z, et al. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res. 2005;19:195-211.
40. Herwick S, Miller FH, Keppke AL. MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol. 2006;187:W472-W480.
41. Ichikawa T, Peterson MS, Federle MP, et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology. 2000;216:163-171.
42. Rappeport ED, Hansen CP, Kjaer A, et al. Multidetector computed tomography and neuroendocrine pancreaticoduodenal tumors. Acta Radiol. 2006;47:248-256.
43. Procacci C, Carbognin G, Accordini S, et al. Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol. 2001;11:1175-1183.